MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including Alzheimer’s and Huntington’s disease, pain, and psychiatric disorders.

Biotechnology

MindImmune Therapeutics

Stevin Zorn

Sourav Kole

Bob Nelson

Frank S. Menniti

The board of directors at MindImmune Therapeutics has a wealth of experience in the industry, with a focus on venture development and investment. Members of the board have worked with companies such as Biograph Venture Development LLC, Slater Technology Fund, and M2S. They also have experience in education, with a focus on venture capital and entrepreneurship.

Board of Directors

About

Team members

Other teams at MindImmune Therapeutics

Leadership Team

CEO and Executive Team